Liver cell self-repair and regeneration

Share This Post

A new study conducted by a biochemist at the University of Illinois has determined how damaged liver cells repair and use signals to repair themselves back to the early stages of organ development. The results of this study were published in the journal Natural Structure and Molecular Biology.

Avinash Kalsotra, a professor of biochemistry who is responsible for the new research, said, “Healthy adult liver cells are dormant and seldom undergo cell division, but if the liver is damaged, the liver cells will re-enter the cell cycle and repair themselves. The liver It is a flexible organ that can repair 70% of the damage and function in a few weeks. “The human liver may be damaged for a long time by toxins such as alcohol or certain drugs, but it will continue to function and repair itself. The study looked at what happened to the damaged liver at the molecular level, allowing it to regenerate while functioning normally.

The researchers used a mouse liver model that was severely damaged by the toxin to compare the injured adult liver cells with healthy cells in the developmental stage just after birth. The study found that the damaged cells could be restored to the gene expression state of the newborn after being partially re-edited. The messenger RNA fragments are rearranged and processed in the manner of neonatal development when hepatocytes are regenerated. This phenomenon is regulated by alternative splicing, where exons (expression regions of genes) are cut out from introns (insertion regions) and spliced ​​together in various combinations to guide the synthesis of different proteins from a single gene. These proteins have different cellular functions or characteristics.

 

The researchers found that liver cells use the specific RNA-binding protein ESRP2 to accurately classify splitable RNA. These RNAs can produce the proteins necessary for adult liver function. When damaged, liver cells reduce the amount of ESRP2 protein. This will reactivate fetal RNA splicing in the Hippo signaling pathway and indicate how to restore and repopulate the liver with new healthy cells. “

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy